Abstract:Background: Estrogen is a vital hormone that regulates many biological functions within the body. These include roles in the development of the secondary sexual organs in both sexes, plus uterine angiogenesis and proliferation during the menstrual cycle and pregnancy in women. The varied biological roles of estrogens in human health also make them a therapeutic target for contraception, mitigation of the adverse effects of the menopause, and treatment of estrogen-responsive tumours. In addition, endogenous (e.g. genetic variation) and external (e.g. exposure to estrogen-like chemicals) factors are known to impact estrogen biology. To understand how these multiple factors interact to determine an individual's response to therapy is complex, and may be best approached through a systems approach. Methods: We present a physiologically-based pharmacokinetic model (PBPK) of estradiol, and validate it against plasma kinetics in humans following intravenous and oral exposure. We extend this model by replacing the intrinsic clearance term with: a detailed kinetic model of estrogen metabolism in the liver; or, a genome-scale model of liver metabolism. Both models were validated by their ability to reproduce clinical data on estradiol exposure. We hypothesise that the enhanced mechanistic information contained within these models will lead to more robust predictions of the biological phenotype that emerges from the complex interactions between estrogens and the body. Results: To demonstrate the utility of these models we examine the known drug-drug interactions between phenytoin and oral estradiol. We are able to reproduce the approximate 50% reduction in area under the concentration-time curve for estradiol associated with this interaction. Importantly, the inclusion of a genome-scale metabolic model allows the prediction of this interaction without directly specifying it within the model. In addition, we predict that PXR activation by drugs results in an enhanced ability of the liver to excrete glucose. This has important implications for the relationship between drug treatment and metabolic syndrome. Conclusions: We demonstrate how the novel coupling of PBPK models with genome-scale metabolic networks has the potential to aid prediction of drug action, including both drug-drug interactions and changes to the metabolic landscape that may predispose an individual to disease development.

A Deterministic, Mathematical Model for Hormonal Control of the Menstrual Cycle

A delay differential equation model of follicle waves in women

Reduced model for female endocrine dynamics: Validation and functional variations

Local and global analysis of endocrine regulation as a non-cyclic feedback system

Mathematical modeling of the GnRH pulse and surge generator

Physiology of the Endometrium and Regulation of Menstruation

Importance of Daily Sex Hormone Measurements Within the Menstrual Cycle for Fertility Estimates in Cyclical Shifts Studies

From Menarche to Regular Menstruation: Endocrinological Background

Physiological Changes During the Menstrual Cycle and Their Effects on the Pharmacokinetics and Pharmacodynamics of Drugs

Menstrual cycle rhythmicity: metabolic patterns in healthy women

High-amplitude network co-fluctuations linked to variation in hormone concentrations over the menstrual cycle

Modelling hematopoiesis mediated by growth factors with applications to periodic hematological diseases

Proof-of-Concept for Long-Term Human Endometrial Epithelial Organoids in Modeling Menstrual Cycle Responses

Linking physiologically-based pharmacokinetic and genome-scale metabolic networks to understand estradiol biology

High-amplitude network co-fluctuations linked to variation in hormone concentrations over menstrual cycle

The Menstrual Cycle as Indicator in Prepregnancy Care

The Effect of Menstrual Cycle Phases on Approach–Avoidance Behaviors in Women: Evidence from Conscious and Unconscious Processes

Idiosyncrasy and generalizability of contraceptive- and hormone-related functional connectomes across the menstrual cycle

Oscillations in a Maturation Model of Blood Cell Production

Is Female Health Cyclical? Evolutionary Perspectives on Menstruation

Menstrual cycle-driven hormone concentrations co-fluctuate with white and gray matter architecture changes across the whole brain